Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

p21-Activated Kinases

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on p21-Activated Kinases:

Pubmed Logo
Identification of novel in vivo phosphorylation sites of the human proapoptotic protein BAD: pore-forming activity of BAD is regulated by phosphorylation.
BAD is a proapoptotic member of the Bcl-2 protein family that is regulated...
11th November, 2009
Institute for Medical Radiation and Cell Research, University of J Biol Chem. 2009 Oct 9;284(41):28004-20. Epub 2009 Aug 10.
DOI Direct Link
Downregulation of p21-activated kinase-1 inhibits the growth of gastric cancer cells involving cyclin B1.
p21-Activated kinase 1 (Pak1), a serine/threonine kinase, has been...
7th November, 2009
Department of Cell Biology, Key Laboratory of Cell Biology, Ministry of Int J Cancer. 2009 Dec 1;125(11):2511-9.
DOI Direct Link
Myosin II regulation during C. elegans embryonic elongation: LET-502/ROCK, MRCK-1 and PAK-1, three kinases with different roles.
Myosin II plays a central role in epithelial morphogenesis; however, its...
3rd November, 2009
IGBMC, CNRS/ INSERM/ UdS, 1 rue Laurent Fries, BP.10142, 67400 Illkirch, Development. 2009 Sep;136(18):3109-19. Epub 2009 Aug 12.
DOI Direct Link
Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: Effects on prognosis and cell invasion.
Ovarian cancer is a gynecological malignancy of high mortality....
31st October, 2009
Department of Pathology and The University of Hong Kong, Queen Mary Int J Cancer. 2009 Oct 28.
DOI Direct Link
Activated actin-depolymerizing factor/cofilin sequesters phosphorylated microtubule-associated protein during the assembly of alzheimer-like neuritic cytoskeletal striations.
In Alzheimer's disease (AD), rod-like cofilin aggregates (cofilin-actin...
31st October, 2009
The Brain & Mind Research Institute, and Bosch Institute, School of J Neurosci. 2009 Oct 14;29(41):12994-3005.
DOI Direct Link

View more research publications.

Press Releases About p21-Activated Kinases:

BioPortfolio Logo
Cardium Reports on Third Quarter 2009 Financial Results and Recent Developments 10th November, 2009 Cardium Therapeutics
-- Listing compliance with the NYSE Amex. Sale of InnerCool Therapies to Royal Philips Electronics During third quarter 2009, Cardium announced the completion of the sale of its InnerCool
Wound Management Technologies Announces Cytokine Study Presentation at the Tri-Society Annual Conference 2009 in Lisbon, Portugal 3rd November, 2009 Wound Management Technologies, Inc.
-- Treatment of diabetic ulcers with activated collagen (CellerateRx) and standard therapy significantly accelerated wound healing compared to standard therapy alone --
Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds 2nd November, 2009 Cardium Therapeutics
SAN DIEGO, Nov. 2 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced plans to submit a 510(k) premarket notification with the U.S. Food and Drug Administration (FDA)
Systagenix Unveils SILVERCEL* Non-Adherent Silver Hydro Alginate Dressing 22nd October, 2009
LONDON, October 22 /PRNewswire/ -- Systagenix Wound Management, has unveiled SILVERCEL* Non-Adherent dressing a powerful new antimicrobial silver dressing with a unique non -adherent layer that
NexGenix Pharmaceuticals Awarded Phase I Grant from the National Institute of Neurological Disorders and Stroke (NINDS) Small Business Innovation Research Program (SBIR) for the Development of Novel Small Molecule Hsp90 Therapeutics to Treat Glioma 22nd October, 2009 NexGenix Pharmaceuticals Holdings, Inc.
NEW YORK, Oct. 22 /PRNewswire/ -- NexGenix Pharmaceuticals Holdings, Inc. a privately-held biotechnology company with a portfolio of novel targeted therapies for oncology and neurodegenerative

p21-Activated Kinases Patents:

USPTO Logo
US Patent No.Title
7556942 Tumor suppressor designated Hippo
6720175 Nucleic acid molecule encoding homer 1B protein
6680170 Polynucleotides encoding STE20-related protein kinases and methods of use
6656716 Polypeptide fragments of human PAK5 protein kinase
6645728 Inhibitor of the inflammatory response induced by TNF.alpha. and IL-1

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for p21-Activated Kinases scientists - we have details of around 80 individuals working on p21-Activated Kinases .


This page has been viewed 264 times
Recent Search Terms used to find this page: wikipedia systagenix wound management uk | p21 activated kinase | p21 activated kinase | p21 kinase | P21 activated protein kinase wiki | protein kinase b wikipedia | p21-activated protein kinase wikipedia | p21 proteins and wikipedia | P21 kinase | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for p21-Activated Kinases across BioPortfolio, or for p21-Activated Kinases Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.